These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 71274)

  • 41. Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.
    Henriksen O; Law LW; Appella E
    J Natl Cancer Inst; 1977 Jun; 58(6):1785-8. PubMed ID: 194045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of human papovavirus T antigens.
    Dougherty RM
    J Gen Virol; 1976 Oct; 33(1):61-70. PubMed ID: 62024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogenicity in newborn and adult Syrian hamsters of SV40 temperature-sensitive (ts) mutants.
    Deichman G; Kashkina L; Rapp F
    Neoplasma; 1979; 26(1):49-56. PubMed ID: 219381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limitation of VSV infection by the host's response to VSV-associated cellular antigens.
    Hecht TT; Paul WE
    J Immunol; 1982 Oct; 129(4):1736-41. PubMed ID: 6180021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
    Puddington L; Bevan MJ; Rose JK; Lefrançois L
    J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum activity inhibiting specific simian virus 40-induced transplantation resistance and its correlation with primary SV40 tumors appearance in hamsters.
    Volpe EA
    Experientia; 1978 Jan; 34(1):113-6. PubMed ID: 202479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface proteins of simian-virus-40-transformed cells.
    Chandrasekaran K; Winterbourne DJ; Luborsky SW; Mora PT
    Int J Cancer; 1981 Mar; 27(3):397-407. PubMed ID: 6169662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limitations and utility of a cytolytic assay for measuring simian virus 40-induced cell surface antigens.
    Pancake SJ; Mora PT
    Cancer Res; 1976 Jan; 36(1):88-94. PubMed ID: 174816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of tumor-specific transplantation antigen in cell lines transformed by wild-type of tsA mutant simian virus 40.
    Chang C; Anderson JL; Martin RG; Mora PT
    J Virol; 1977 May; 22(2):281-9. PubMed ID: 194055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
    Ting CC; Rodrigues D; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
    [No Abstract]   [Full Text] [Related]  

  • 52. Tumorigenicity of persistently infected tumors in nude mice is a function of both virus and host cell type.
    VandePol SB; Holland JJ
    J Virol; 1986 Jun; 58(3):914-20. PubMed ID: 3009896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Properties of SV 40 rescued from actinomycin D-sensitive and actinomycin D-resistant transformed hamster cells. II. Transforming capacity, oncogenicity, TSTA induction.
    Wicker R; Cassingena R; Suarez HG; Estrade S; Lavialle C; Lazar P
    Arch Gesamte Virusforsch; 1974; 46(3-4):217-28. PubMed ID: 4375443
    [No Abstract]   [Full Text] [Related]  

  • 54. Cell properties after repeated transplantation of spontaneously and of SV40 virus transformed mouse cell lines. I. Growth in culture.
    McFarland VW; Mora PT; Schultz A; Pancake S
    J Cell Physiol; 1975 Feb; 85(1):101-11. PubMed ID: 162906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
    Shearer MH; Bright RK; Lanford RE; Kennedy RC
    Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic selection against simian virus-40 transformed cells: concomitnat loss of viral antigens and early viral gene sequences.
    Kuster JM; Mora PT; Brown M; Khoury G
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4796-800. PubMed ID: 200932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New antigens in cells transformed by the SV40 virus. 3. Presence of an SV40-coded antigen on the surface of different cell lines transformed by this virus (author's transl)].
    Duthu-Herbet A; Kress M; de Vaux Saint Cyr C
    Int J Cancer; 1973 Jul; 12(1):290-300. PubMed ID: 4364271
    [No Abstract]   [Full Text] [Related]  

  • 59. Detergent solubilization and partial purification of tumor specific surface and transplantation antigens from SV40-virus-transformed mouse cells.
    Chang C; Pancake SJ; Luborsky SW; Mora PT
    Int J Cancer; 1977 Feb; 19(2):258-66. PubMed ID: 190177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ribosomal proteins in normal simian cells, SV40-transformed simian cells, and simian cells infected with SV40, adenovirus 5, and vesicular stomatitis virus.
    Bosselman RA; Price JA; Burns AL; Kaulenas MS; Norkin LC
    Intervirology; 1978; 9(1):8-15. PubMed ID: 202574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.